Atara Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $40,190 | $28,640 | $27,357 | $4,252 |
Gross Profit | 32,588 | 24,013 | 25,372 | 1,092 |
EBITDA | -19,513 | -16,457 | -29,184 | -58,058 |
EBIT | -20,743 | -17,787 | -30,575 | -59,263 |
Net Income | -21,909 | -19,049 | -317,520 | -604,500 |
Net Change In Cash | 40,190 | 28,640 | 27,357 | 4,252 |
Free Cash Flow | -3,989 | -10,674 | -29,739 | -50,450 |
Cash | 46,453 | 31,314 | 35,233 | 25,987 |
Basic Shares | 7,466 | 6,143 | 5,623 | 4,325 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $8,573 | $63,573 | $20,340 | $3,552 |
Gross Profit | -313 | 49,005 | 20,340 | -9,867 |
EBITDA | -265,997 | -213,722 | -331,117 | -300,720 |
EBIT | -270,826 | -228,290 | -340,462 | -309,052 |
Net Income | -276,126 | -2,283,020 | -340,141 | -306,620 |
Net Change In Cash | 8,573 | 63,573 | 20,340 | 3,552 |
Cost of Revenue | -14,390 | -94,320 | 126,087 | |
Free Cash Flow | -194,200 | -274,623 | -231,102 | -185,272 |
Cash | 25,841 | 92,942 | 106,084 | 200,404 |
Basic Shares | 4,236 | 4,079 | 3,746 | 2,958 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.93 |
2024-06-30 | -$3.10 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.56 |
